ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorColumbia University
About this trial
The novel coronavirus (SARS-CoV-2) has spread all around the world and testing has posed a challenge globally. Health care providers are highly exposed and are an important group to test. On top of these concerns, health care workers are also stressed by the needs on responders in the COVID-19 crisis. The investigators will look at different ways to measure how common COVID-19 is among health care workers, how common is the presence of antibodies by serological tests (also known as serostatus). The investigators will describe health worker mental and emotional well-being and their coping strategies in their institutional settings. Lastly, the investigators will describe how knowing serostatus can affect individuals' mental and emotional well-being and how to cope in the midst of the COVID-19 response. This will help to how to better test and help healthcare workers in the COVID-19 pandemic and prepare for possible future outbreaks.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
18 years of age or older
NewYork-Presbyterian (NYP) healthcare personnel employee or affiliate
Understands and reads English
Disqualifiers
Younger than 18 years of age
Mentally and/or physically unable to complete study requirements
Trial population
Employee of NewYork-Presbyterian Hospital and its affiliates
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
COVID-19 Serology
Other interventionQuantitate Serology enzyme-linked immunosorbent assay (ELISA) for COVID-19
Health Care Worker Survey
BehavioralThe purpose of this survey is to assess how healthcare workers are experiencing and coping with the COVID-19 crisis.
Treatment groups
1,000 Participants
are divided into 4 treatment groupsGroup A: Prior Positive polymerase chain reaction (PCR) and Recovered2 interventions
Group B: Never tested, history of COVID-19 Symptoms and Recovered2 interventions
Group C: Never tested and current COVID-19 Symptoms2 interventions
Group D: Never tested and asymptomatic2 interventions
Trial outcomes
Primary outcomes
1
Proportion seropositive
Percentage of health care workers with positive serological markers to describe patterns in exposure, re-infection, clinical symptom, serological responses among health care workers based on their baseline serological status over a one year period.
Time frame
Up to 12 months after collection visitSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov